These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 925608)

  • 41. Antigens associated with various cytotoxic activities of murine peripheral macrophages.
    Okutomi T; Satoh M; Oshima H; Yamazaki M
    Microbiol Immunol; 1986; 30(10):1037-47. PubMed ID: 3540536
    [TBL] [Abstract][Full Text] [Related]  

  • 42. In vitro and in vivo cytotoxicity of adriamycin and daunomycin for murine macrophages.
    Mantovani A
    Cancer Res; 1977 Mar; 37(3):815-20. PubMed ID: 837378
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A comparison of the antitumour activities of glucans and C. parvum.
    Bomford R; Moreno C
    Dev Biol Stand; 1977 Apr 13-15; 38():291-5. PubMed ID: 608513
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Factor B, the complement alternative pathway serine proteinase, is a major constitutive protein synthesized and secreted by resident and elicited mouse macrophages.
    Sundsmo JS; Chin JR; Papin RA; Fair DS; Werb Z
    J Exp Med; 1985 Feb; 161(2):306-22. PubMed ID: 3844438
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Receptors for immunoglobulin and complement on mouse leukemias and lymphomas.
    Shevach E; Herberman R; Lieberman R; Frank MM; Green I
    J Immunol; 1972 Feb; 108(2):325-8. PubMed ID: 4340285
    [No Abstract]   [Full Text] [Related]  

  • 46. Splenic suppressor macrophages induced in mice by injection of Corynebacterium parvum.
    Kirchner H; Holden HT; Herberman
    J Immunol; 1975 Nov; 115(5):1212-6. PubMed ID: 1176773
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The effect of a single and repeated administration of Corynebacterium parvum on bone marrow macrophage colony production in syngeneic tumor-bearing mice.
    Wolmark N; Fisher B
    Cancer Res; 1974 Nov; 34(11):2869-72. PubMed ID: 4419513
    [No Abstract]   [Full Text] [Related]  

  • 48. The characteristics of binding of Corynebacterium parvum to glass-adherent mouse peritoneal exudate cells.
    Ogmundsdóttir HM; Weir DM
    Clin Exp Immunol; 1976 Nov; 26(2):334-9. PubMed ID: 991461
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Macrophages as effector cells of protective immunity in murine schistosomiasis. V. Variation in macrophage schistosomulacidal and tumoricidal activities among mouse strains and correlation with resistance to reinfection.
    James SL; Skamene E; Meltzer MS
    J Immunol; 1983 Aug; 131(2):948-53. PubMed ID: 6863937
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Inability of tumour cells to elicit the respiratory burst in cytotoxic, activated macrophages.
    Bryant SM; Hill HR
    Immunology; 1982 Mar; 45(3):577-85. PubMed ID: 6277777
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Localization of a macrophage chemokinetic factor on neoplastic cells.
    Lane RD; Kaplan AM; Snodgrass MJ; Spriggs DJ; Szakal AK
    J Natl Cancer Inst; 1984 Apr; 72(4):871-84. PubMed ID: 6368941
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The role of macrophages in the adjuvant effect on antibody production of Corynebacterium parvum.
    Watson SR; Sljivić VS
    Clin Exp Immunol; 1976 Jan; 23(1):149-53. PubMed ID: 770033
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Mechanism of nonspecific macrophage-mediated cytotoxicity: evidence for lack of dependence upon oxygen.
    Sorrell TC; Lehrer RI; Cline MJ
    J Immunol; 1978 Feb; 120(2):347-52. PubMed ID: 340584
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Macrophage activation: dissociation of cytotoxic activity from Ia-A antigen expression.
    Blumenthal EJ; Roberts WK; Vasil A; Talmage DW
    Proc Natl Acad Sci U S A; 1983 Apr; 80(7):2031-5. PubMed ID: 6572960
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Further observations on the inhibition of tumor growth by Corynebacterium parvum with cyclophosphamide. IX. Macrophage content of tumors in mice.
    Gebhardt MC; Fisher B
    J Natl Cancer Inst; 1979 Apr; 62(4):1035-41. PubMed ID: 285276
    [No Abstract]   [Full Text] [Related]  

  • 56. Immunological enhancement of leukemia L1210 by Corynebacterium parvum in allogeneic mice.
    Berd DA; Mitchell MS
    Cancer Res; 1976 Nov; 36(11 Pt 1):4119-24. PubMed ID: 975053
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Interferon production by Corynebacterium parvum and BCG-activated murine spleen macrophages.
    Neumann C; Macher E; Sorg C
    Immunobiology; 1980 Apr; 157(1):12-23. PubMed ID: 6162779
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Defective tumoricidal capacity of macrophages from P/J mice: characterization of the macrophage cytotoxic defect after in vivo and in vitro activation stimuli.
    Boraschi D; Meltzer MS
    J Immunol; 1980 Aug; 125(2):771-6. PubMed ID: 6993562
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Apoprotein E is synthesized and secreted by resident and thioglycollate-elicited macrophages but not by pyran copolymer- or bacillus Calmette-Guerin-activated macrophages.
    Werb Z; Chin JR
    J Exp Med; 1983 Oct; 158(4):1272-93. PubMed ID: 6619735
    [TBL] [Abstract][Full Text] [Related]  

  • 60. B cell stimulatory factor-1 (interleukin 4) activates macrophages for increased tumoricidal activity and expression of Ia antigens.
    Crawford RM; Finbloom DS; Ohara J; Paul WE; Meltzer MS
    J Immunol; 1987 Jul; 139(1):135-41. PubMed ID: 3108395
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.